Malovecká, I. 1, Papargyris, K. 1, Mináriková, D. 1, Foltán V. 1, Jankovská, A. 2

Similar documents
OECD HEALTH SYSTEM CHARACTERISTICS SURVEY 2012

Payroll Taxes in Canada from 1997 to 2007

OECD Report Shows Tax Burdens Falling in Many OECD Countries

THE ASSET CORRELATION ANALYSIS IN THE CONTEXT OF ECONOMIC CYCLE

ABOLISHING CASH IN EUROPE: THE BENEFITS AND DRAWBACKS OF ELECTRONIC TRANSACTIONS

), is described there by a function of the following form: U (c t. )= c t. where c t

Can Working Lives be Extended? Problems and Prospects for Older Workers

Making the case for Horizon Scanning

Medicare Prescription Drug, Improvement and Modernization Act

COMMISSION OF THE EUROPEAN COMMUNITIES REPORT FROM THE COMMISSION. Slovakia. Report prepared in accordance with Article 104(3) of the Treaty

Analysis of CBO s Budget Outlook: Fiscal Years

LA COPERTURA DEI SERVIZI SANITARI NEI PAESI OCSE. Annalisa Belloni

Federal Tax Reform NCSL Executive Committee Task Force on State and Local Taxation Jackson, Wyoming June 16, 2017

Economics of Policy Issues EC3060 Autumn 2016

The Economics of Public Health Care Reform in Advanced and Emerging Economies

National Treasury. Financing NHI. Pharmaceutical Society SA 24 June 2018

Faster access of patients to new medicines Revised Transparency Directive

TAX REVENUES, STATE BUDGET AND PUBLIC DEBT OF SLOVAK REPUBLIC IN RELATION TO EACH OTHER

2011 NCPA. DigesT FINANCIAL BENCHMARKS

Sponsored by Cardinal Health

IARJSET. Economics and Business Department, Esa Unggul University, Jakarta, Indonesia 1,2,3,4 I. INTRODUCTION

ScienceDirect. Economic Value Added as a measurement tool of financial performance

Brief on Fair Drug Prices in New Brunswick

Investment in Health is investment in wealth: the positive dimension of healthcare K. Panagoulias, Al.President SFEE

CAH Financial Indicators Report: Summary of Indicator Medians by State

Taiwan OTC market overview. The opportunities and challenges in OTC. Future outlook

CAH Financial Indicators Report: Summary of Indicator Medians by State

CASH FLOWS OF INVESTMENT PROJECTS A MANAGERIAL APPROACH

E u r o E c o n o m i c a

Energy poverty (Vulnerable consumers) in EU

Introduction to the US Health Care System. What the Business Development Professional Should Know

Survey of the Average Cost of Dispensing a Medicaid Prescription in the State of Alaska

Pocket guide to Investing in European health R&D

Cost Analysis Data Entry Workbook Guide

Mergers and acquisitions in Poland in the context of Central and Eastern Europe between 2002 and 2006 trends and perspectives

Investment Report The Flexible Guarantee Bond and Flexi Guarantee Plan

Pensions at a Glance 2009: Retirement-Income Systems in OECD Countries

Americans & Health Care Reform: How Access and Affordability Are Shaping Views. Summary of Survey Findings Prepared for: Results for America

Reforming Policies for Regional Development: The European Perspective

46 ECB FISCAL CHALLENGES FROM POPULATION AGEING: NEW EVIDENCE FOR THE EURO AREA

Comparison between Macedonian and Albanian Retail Banking Sector

FINANCING SMES AND ENTREPRENEURS 2016: AN OECD SCOREBOARD HIGHLIGHTS

Tax Burden, Tax Mix and Economic Growth in OECD Countries

SMEs contribution to the Maltese economy and future prospects

CLAIM FORM INSTRUCTIONS

COMPARATIVE ANALYSIS OF SOCIAL PROTECTION IN GREECE AND ROMANIA, PERIOD

2 Macroeconomic Scenario

DOES COMPENSATION AFFECT BANK PROFITABILITY? EVIDENCE FROM US BANKS

The Pharmaceutical Industry, Drug Prices and Value

NBP Quick Monitoring Survey

SESSION 3 The market forces framework in Primary Care Services Markets

FINANCE & DEVELOPMENT

OECD Health Policy Unit. 10 June, 2001

The Chilean Pension System: Favorable Results in International Comparison

The Funding Landscape for Small Biopharma Ventures,

NPO FUNDING & SERVICE CUTS

Seniors and the Medicare Prescription Drug Benefit

Tort law reform for personal injury claims is it needed and does it work? An international perspective. Tony Mason 29th September 2017

Income smoothing and foreign asset holdings

Health Care Financing: Looking Towards Kurdistan s Future

The Canadian Pharmacists Association Response to Proposed Regulation Changes under the Drug Interchangeability and Dispensing Fee Act (DIDFA)

FIRM-LEVEL BUSINESS CYCLE CORRELATION IN THE EU: SOME EVIDENCE FROM THE CZECH REPUBLIC AND SLOVAKIA Ladislava Issever Grochová 1, Petr Rozmahel 2

Folia Oeconomica Stetinensia DOI: /foli Progress in Implementing the Sustainable Development

Drug Reimbursement - Croatia. Roganovic Jelena

Ageing Workforce in an Ageing Society Switzerland s challenge to totally replace its health professionals by 2030

The Medium-term Financial Sustainability of the Czech public Health Insurance System

GREEK ECONOMIC OUTLOOK

Pay in the public services how workers continue to pay for the crisis

Competition Policy in a Small Economy: the Case of Iceland

Healthcare Financial Management Association

EXECUTIVE OFFICE OF THE PRESIDENT COUNCIL OF ECONOMIC ADVISERS WASHINGTON, DC 20502

MODELLING HEALTH MAINTENANCE ORGANIZATIONS PAYMENTS UNDER THE NATIONAL HEALTH INSURANCE SCHEME IN NIGERIA

How costly is for Spain to be in the EURO?

DR. FRIEDMAN FINANCIAL STUDY EXECUTIVE SUMMARY DECEMBER 2017

MULTINATIONAL COMPANIES AND FOREIGN DIRECT INVESTMENT

The Cost of Specialty Drugs: Payer Perspectives

Survey of the Average Cost of Dispensing a Medicaid Prescription in the State of Texas

Chapter 12 Government and Fiscal Policy

The current state of the Japanese Economy and mid- to long-term challenges it faces

REAL OR DECLARATIVE READINESS OF STAKEHOLDERS FOR EUROPEAN UNION FUNDS?

Recommendations for the Special Joint Committee on Deficit Reduction

Determinants of loans in Slovakia

Value Choice. Summary of Benefits. January 1 December 31, 2014 S5660 & S5983. Y0046_B00SNS4B Accepted

Barbora Drugdová. University of Economics in Bratislava, Bratislava, Slovak Republic

Managing Healthcare Expenditures: Fiscal Projections and Effects of Reforms

Brady Brewer, Allen Featherstone, Christine Wilson, and Brian Briggeman Department of Agricultural Economics Kansas State University

REPORT FROM THE COMMISSION. State Aid Scoreboard. Report on state aid granted by the EU Member States. - Autumn 2012 Update. {SEC(2012) 443 final}

A STUDY ON FACTORS INFLUENCING OF WOMEN POLICYHOLDER S INVESTMENT DECISION TOWARDS LIFE INSURANCE CORPORATION OF INDIA POLICIES IN CHENNAI

MONITORING POVERTY AND SOCIAL EXCLUSION IN SCOTLAND 2015

Inside: Critical information about your company s prescription drug benefit.

Trade Performance in EU27 Member States

Aleksandra Dyba University of Economics in Krakow

LOW EMPLOYMENT INTENSITY OF GROWTH AND SPECIFICS OF SLOVAK LABOUR MARKET

TRENDS IN INCOME DISTRIBUTION

Notes Numbers in the text and tables may not add up to totals because of rounding. Unless otherwise indicated, years referred to in describing the bud

Pharmaceuticals: Can or Should We Do Anything About Rising Drug Costs? Caroline F. Pearson

Equity financing and investment opportunities in Canadian primary agriculture

In fiscal year 2016, for the first time since 2009, the

Sample Performance Review

Corrigendum. OECD Pensions Outlook 2012 DOI: ISBN (print) ISBN (PDF) OECD 2012

Transcription:

ISSN 1338-6786 (online) and ISSN 0301-2298 (print version), DOI: 10.1515/afpuc-2015-0015 ACTA FACULTATIS PHARMACEUTICAE UNIVERSITATIS COMENIANAE Prosperity of community pharmacy evaluated by gross and net profit and suggested corrective measures. 10 years study Prosperita verejnej lekárne hodnotená prostredníctvom hrubého a čistého zisku a opatrenia vedúce k ich náprave. 10 ročná štúdia Original research article Malovecká, I. 1, Papargyris, K. 1, Mináriková, D. 1, Foltán V. 1, Jankovská, A. 2 1 Comenius University in Bratislava, Faculty of Pharmacy, Department of Organisation and Management in Pharmacy, Bratislava, Slovak Republic 2 University of Economics in Bratislava, Faculty of National Economy, Department of Finance, Banking and Investment, Bratislava Slovak Republic / 1 Univerzita Komenského v Bratislave, Farmaceutická fakulta, Katedra organizácie a riadenia farmácie, Bratislava, Slovenská republika 2 Ekonomická Univerzita v Bratislave, Národohospodárska Fakulta, Katedra financií, bankovníctva a investovania, Bratislava, Slovenská republika Received January 2, 2015, accepted April 4, 2015 Abstract Slovak abstract Monitoring, calculation and assessment of community pharmacy prosperity with the help of financial analysis indicators for years 2003 2012, using financial statements was conducted, with respect to profitability parameters such as gross and net profit ratios. These ratios reflect various changes that hold between years 2003 and 2012. Under the time of financial crisis, recession and serious socioeconomic changes the profitability parameter gross profit ranged from x 2003 2011 =14.3 22.8% (average=19.2%, mean=19.8%, σ=2.4), but in 2012 decreased on 14.3%. Net profit ranged x 2003 2011 = 2.3 18.3% (average=14.6%, mean =16.6%, σ = 4.9), while in 2012 reached only 2.3%. All changes that have taken place in the society had impact on community pharmacy finance by worsening its profitability. Therefore, the stability of community pharmacy may be threatened and may affect its future performance. Monitorovanie, výpočet a hodnotenie prosperity verejnej lekárne pomocou metódy finančnej analýzy z účtovných dokladov bolo uskutočnené za roky 2003 2012. Počítané boli ukazovatele ziskovosti, ako hrubý a čistý zisk. Ukazovatele odrážajú mnohé zmeny, ktoré nastali v rokoch 2003 až 2012. V dôsledku finančnej krízy, recesie a vážnych socioekonomických zmien sa ukazovateľ hrubého zisku pohyboval v rozpätí x 2003-2011 = 14,3-22,8 % (priemer = 19,2 %, median = 19,8 %, σ = 2,4), ale v roku 2012 klesol na 14,3 %. Ukazovateľ čistého zisku sa pohyboval v rozpätí x 2003-2011 = 0-18,3 % (priemer = 14,6 %, median = 16,6 %, σ = 4,9), zatiaľ čo v roku 2012 dosiahol len 2,3 %. Zmeny ktoré prebehli v spoločnosti mali dopad na ekonomiku verejnej lekárne. Prejavili sa zhoršením jej ziskovosti, a tým ohrozením stability verejnej lekárne do budúcnosti. Keywords community pharmacy prosperity financial analysis gross profit net profit corrective measures financial crisis Kľúčové slová: verejná lekáreň prosperita fianačná analýza hrubý zisk čistý zisk nápravné opatrenia finančná kríza INTRODUCTION Community pharmacies nowadays play a crucial role in the health status of a society. They are health care units designed to provide pharmaceutical care. They constitute the direct providers of medicines and the basic contributors in the provision of pharmaceutical services to patients (Cheng et al., 2013). Once financial crisis started to spread worldwide, it was anticipated the affection of more and more countries by this global phenomenon and the expansion of a negative impact on their economic growth and development (Ifanti et al., 2013). Financial crisis, characterised by general economic slowdown, reduced retail growth and decreased profit margins, has placed the health care system into a very difficult position (Gorantis et al., 2014). Also the employees feel the impact of the recent economic crisis on employee workrelated attitudes via changes in regulatory focus (Markovits et al., 2014). At the present time, community pharmacy is going through very tough moments, since it daily faces financial constraints * E-mail: malovecka@fpharm.uniba.sk Acta Facultatis Pharmaceuticae Universitatis Comenianae 20

Malovecká, I. et al. and economic pressure (Vogler et al., 2014). Furthermore, health care market has been deregulated in such a way that revenues are diminished for the new participants entering the market. All these effects of financial crisis are creating a considerable financial pressure on community pharmacy which is also daily confronted with accelerated competition (Jacobs et al., 2013). In order to alleviate the problems, generated mainly by financial crisis, the role of the pharmacist is gradually and progressively changing (Bush et al., 2009; McMillan et al., 2013). Despite the difficult time that it faces, community pharmacy must maintain its operation and survive at the upcoming time (Norris et al., 2014). Except for social and medical objectives, there is also the economic objective of a community pharmacy that is focused on generating profit. Gaining profit is of great importance not only for the existence of the community pharmacy but also for its further development (Keast et al., 2010, Perepelkin and Dobson, 2010). Gaining profit can be limited by the provision of pharmaceutical care to concrete patients (Carroll et al., 1996). In order to assure its financial stability, a community pharmacy should possess and manage sufficient funds so as to cover its obligations and to normally run the business. During the normal operation of a community pharmacy, in the provision of pharmaceutical care, inputs form the bulk of the costs and outputs the revenues. The difference between costs and revenues is the profit of the community pharmacy. Operating order of the community pharmacy is required so as to ensure its proper operation (Herist et al., 2011). The necessary parts that contribute to this proper operation include the existence and careful management of organisational structure of the pharmacy, pharmacy premises, pharmacy stuff and their premises as well as loyal following of a hygienic and sanitation program. AIMS AND OBJECTIVES The principal objective of the work is to assess the financial performance of pharmacy services provided by an independent community pharmacy. Article focuses on total revenue and costs of the community pharmacy s overall operations. Ten years (2003 2012) of pharmacy records are examined in order to evaluate the profitability characteristics such as gross and net profit ratios. These ratios constitute significant parameters in providing useful information concerning the financial health of the independent community pharmacy. The better the understanding of the profitability ratios, the greater will be the improvement in managing and controlling the services and finances of the independent community pharmacy. METHODOLOGY AND RESEARCH METHODS The methodology conducted relies on the calculation, monitoring and assessment of financial indicators which are critical for the financial analysis of the independent community pharmacy business. The evaluation of profitability indicators is based on the analysis of the figures reported on the financial statements of the enterprise. They are profit and loss statement and balance sheet. Examined data were collected for the period 2003 2012. After acquisition, financial data were converted into ratios to provide a complete view of the community pharmacy s business, adjustments for inflation to overcome the shortfalls that may occur in a longer decade analysis. The calculation for Gross profit margin ratio (%) = (gross profit income) 100 and for Net profit margin ratio (%) = (net profit income) 100. RESULTS AND DISCUSSION The analyzed profitability ratios of the community pharmacy during the given decade had the course shown in the graphic illustration 1. To observe from the graphic illustration, gross profit margin ratio fell in 2004 and since 2005 has remained relatively flat up to 2009. In 2010, there has been an inclining trend to the ratio but afterward the gross margins have recorded a significant downward trend. This declining trend was culminated in 2012, the year that has been recorded the lowest value of the Figure 1. Annual profitability ratios (gross and net profit margin ratios) of the community pharmacy for the years 2003 2012 21

Prosperity of community pharmacy evaluated by gross and net profit and suggested... gross profit margin ratio (14.3, average=19.2%, mean=19.8%, σ=2.4) in comparison with the whole examined decade. This declining trend signifies that community pharmacy generates a low level of revenue to pay for its operating expenses and net profit. Also it indicates that the enterprise is not keeping production and inventory costs under control. Moreover, it may also mean that prices have been set too low. In order to inhibit this downward trend of the ratio, the examined community pharmacy should promptly proceed to the implementation of some necessary corrective actions. Such actions include suggestions towards the improvement of the business s operations. Community pharmacy in order to remain financially viable should decrease the cost of goods sold and generally develop a better managing and control of cost of goods sold (COGS). Also it should manage and revise pricing either by setting prices higher or even by decreasing possible cash discounts. Obviously, higher gross profit is more advantageous than lower one, since making a profit is the primary business objective. Higher sales prices and lower inventory purchase prices are both contributing to maximise gross profit. Therefore, by performing such improvements, examined community pharmacy will find it less difficult to maintain acceptable gross margins to pay the personnel and operating costs of the business s managing. The net profit margin ratio in the observed decade fell in 2004 as well as gross profit margin and since 2005 has remained relatively flat up to 2010. In 2011, it has been recorded a significant downward trend to the ratio. This declining trend was culminated in 2012, year that it has been recorded the lowest value of net profit margin ratio (2.3, average=14.6%, mean =16.6%, σ = 4.9) in comparison with the values achieved during the whole examined decade. The last accelerated declining tendency of the ratio reflects an alarming condition for the independent community pharmacy. It primarily shows that community pharmacy is not generating enough sales and additionally that its gross profit margin is relatively low. Furthermore, it denotes that the business is unable to keep operating expenses under control so as to leave an acceptable profit. Also, such a decrease in the ratio as reported on 2012 may signify a business s susceptibility to cost blowouts. The final value of the ratio reflects that community pharmacy is almost generating no profit for its operations, condition that might indicate the need to take on debt to pay its expenses. In order to survive from this alarming downtrend of the net profit margin ratio, examined community pharmacy should mandatorily and directly proceed to the implementation of certain appropriate corrective actions. Such actions should be instantly performed, since at this moment, community pharmacy has been financially placed one step before taking on debt. The most prominent action that community pharmacy s business should take in order to remain financially viable is to try and reduce fixed and variable costs. Decreasing payroll expenses should be an essential and vital remedial effort. Payroll expenses include all wages and salaries, employee taxes and generally all benefits for all staff of the business including owners (Malovecka et al, 2013). Moreover, community pharmacy should also decrease all other operating expenses, frequently referred to as overhead. These expenses include advertising, insurance, store supplies, containers and labels, delivery expenses, office postage, computer expenses, rent, utilities and telephone. Additionally, it should decrease COGS and revise pricing so as to achieve higher gross profit margins. Except for lowering its payroll expenses and controlling other operating expenses, community pharmacy should proceed to certain efficiency improvements such as increasing the use of technology through investing in laborsaving technologies. Besides, enterprise should look over obtaining revenue for medication therapy management services provided (Smith et al., 2014). By performing such corrective actions, business s net profit margin ratio annual values will slowly but surely conduct an increasing trend. As a result, examined community pharmacy will strengthen its financial position over time and progressively start to generate an acceptable profit in the near future. Many external and internal factors affect the public pharmacy performance. The number of patients customers visited the pharmacy can be marked as a crucial factor (Radford et al., 2009) that affects income and turnover of the enterprise. This factor is not included in methods of financial analysis. Therefore we considered it necessary to evaluate. As it is not a part of financial analysis we have to assess it separately. The statistical information of the examined decade was obtained from the accounting office of the enterprise after taking into account all sales and receipts of the business for every single year. Table 1 provides an overview of the annual amount of customers who visited the pharmacy and the approximate average amount of patients who visited the pharmacy each single day of every examined fiscal year. On 2005 was recorded an increasing trend to the number of customers who visited the pharmacy. From 2005 up to 2008, the amount of customers who visited the pharmacy remained relatively flat. However, from 2009 up to 2012, it has been observed an accelerated declining trend to the annual and daily amount of patients who visited the pharmacy. This condition obviously reflects the deep impact of the financial crisis to the pharmacy practice. The dramatically decreased number of customers during the last four years explains the problematic ability of the business to generate profit. The accelerated changes in the financial and economic profile of the country led people to minimise their visits to the pharmacy and become more conservative in their expenses for pharmaceutical goods or services (Sánchez-Serrano, 2011). During the period of recession, serious socioeconomic changes occurred. Salaries of employees, pensions and other benefits that were handed out in reasonable levels before the crisis have been reduced dramatically (Matsaganis, 2013). This condition resulted in a noticeable decrease in the ability of consumers to purchase products intended both for health and cosmetic aspects (Soderberg, 2012). In specific, 22

Malovecká, I. et al. Table 1. Number of customers who visited the community pharmacy Customers visited the community pharmacy Number of customers per year Average number of customers per working day Fiscal year 2003-2012 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 average mean min max 27240 25548 31284 29492 29500 29885 23305 20810 18619 15099 25078 26394 15099 29885 101 95 116 109 109 111 86 77 69 56 93 98 56 111 it has been observed a significant change in the habits and behavior of consumers, guiding them to decrease their spontaneous purchases, postponing possible purchases and generally decrease their total purchases (Belvis et al., 2012). Furthermore, the priorities of customers in buying products have been switched over, to either choosing the cheapest form or not buying anything at all, even at the cost of their own health (Ásgeirsdóttir et al., 2014). This situation caused a serious decrease in the income of the pharmacy and posed limitations on the ability of pharmacists to ensure financial stability for their businesses. ACKNOWLEDGMENT This contribution/publication is the result of the project implementation: Comenius University in Bratislava Science Park supported by the Research and Development Operational Programme funded by the ERDF Grant number: ITMS 26240220086. CONCLUSION Evaluation of community pharmacy operations and overall performing is essential at the time of financial crisis, recession and serious socioeconomic changes. Using the method of financial analysis and valuating gross and net profit ratios can bring the owner or manager of community pharmacy a lot of benefits towards prosperity and future development of the community pharmacy. Analysis not only tells about the performance of the community pharmacy s business but also helps to determine its overall financial health and tells what might be the future. Podporujeme výskumné aktivity na Slovensku/Projekt je spolufinancovaný zo zdrojov EÚ References [1] Cheng Y, Raisch D W, Borrego ME, Gupchup GV. Research in Social and Administrative Pharmacy, 9(3), 2013, 311-329. [2] Ifanti AA, Argyriou AA, Kalofonou FH, Kalofonos HP. Financial crisis and austerity measures in Greece: Their impact on health promotion policies and public health care. Health Policy, 113 (1 2), 2013, 8-12. [3] Goranitis I, Siskou O, Liaropoulos L. Health policy making under information constraints: An evaluation of the policy responses to the economic crisis in Greece. Health Policy, Accepted Manuscript, Available online 1 August 2014 [4] Markovits Y, Boer D, van Dick R. Economic crisis and the employee: The effects of economic crisis on employee job satisfaction, commitment, and self-regulation. European Management Journal, 32 (3), 2014, 413-422. [5] Jacobs S, Schafheutle EI, Jee SD, Elvey R, Hassell H, Noyce PR. Existing arrangements for monitoring community pharmacies in England: Can they have a role in the revalidation of pharmacists? Research in Social and Administrative Pharmacy, 9(2), 2013, 166-177. [6] Bush J, Langley CA, Wilson KA. The corporatization of community pharmacy: Implications for service provision, the public health function, and pharmacy s claims to professional status in the United Kingdom. Research in Social and Administrative Pharmacy, 5(4), 2009, 305-318. [7] McMillan SS, Wheeler AJ, Sav A, King MA, Whitty JA, Kendall E, Kell F. Community pharmacy in Australia: A health hub destination of 23

Prosperity of community pharmacy evaluated by gross and net profit and suggested... the future. Research in Social and Administrative Pharmacy, 9(6), 2013, 863-875. [8] Keast SL, Jacobs E, Harrison D, Farmer K, Thompson D. Future economic outlook of Nebraska rural community pharmacies based on break-even analysis of community operational costs and county population. Research in Social and Administrative Pharmacy, 6(3), 2010, 209-220. [9] Norris P, Horsburgh S, Sides G, Ram, Fraser J. Geographical access to community pharmacies in New Zealand. Health & Place, 29(1), 2014, 140-145. [10] Perepelkin J, Dobson RT. Influence of ownership type on role orientation, role affinity, and role conflict among community pharmacy managers and owners in Canada. Research in Social and Administrative Pharmacy, 6(4), 2010, 280-292. [11] Carroll NC, Miederhoff PA, Waters LW. Profitability, third-party reimbursement, and access to community pharmacies. Clinical Therapeutics, 8(4), 1996, 703-715. [12] Herist N, Rollins B, Perri M. Financial Analysis in Pharmacy Practice. London: Pharmaceutical Press; 2011. [13] Burke S, Thomas S, Barry S, Keegan C. Indicators of health system coverage and activity in Ireland during the economic crisis 2008 2014 From more with less to less with less. Health Policy, In Press, Corrected Proof, Available online 17 July 2014 [14] Vogler S, Habimana K, Art D. Does deregulation in community pharmacy impact accessibility of medicines, quality of pharmacy services and costs? Evidence from nine European countries. Health Policy, In Press, Corrected Proof, Available online 8 June 2014. [15] Matsaganis M, The Greek Crisis: Social Impact and Policy Responses, Department of Western Europe/North America, Berlin, 2013. [16] de Belvis AG, Ferrè F, Specchia MC, Valerio L, Fattore G, Ricciardi W. The financial crisis in Italy: Implications for the healthcare sector. Health Policy, 106(1), 2012, 10-16. [17] Ásgeirsdóttir TL, Corman H, Noonan K, Ólafsdóttir P, Reichman NE. Was the economic crisis of 2008 good for Icelanders? Impact on health behaviors. Economics & Human Biology, 13(1), 2014, 1-19. [18] Sánchez-Serrano I. The World s Health Care Crisis: The United States Leadership. The World s Health Care Crisis, 2011, 3-28. [19] Söderberg IL, Wester M. Lay actions in the face of crisis Swedish citizens actions in response to the global financial crisis of 2008. The Journal of Socio-Economics, 41(6), 2012, 796-805. [20] Malovecká I, Mináriková D, Lehocká Ľ, Foltán V. New types of assessments of community pharmacy technology business and ther contribution towards prosperity of the community pharmacy. Acta Facultatis Pharmaceuticae Universitatis Comenianae. 2013, 60(1), 35-42. [21] Smith M, Cannon-Breland ML, Spiggle S. Consumer, physician, and payer perspectives on primary care medication management services with a shared resource pharmacists network. Research in Social and Administrative Pharmacy, 10 (3), 2014, 539-553. [22] Radford A, Mason M, Richardson I, Rutledge S, Poley S, Mueller K, Slifkin R. Continuing effects of Medicare Part D on rural independent pharmacies who are the sole retail provider in their community. Research in Social and Administrative Pharmacy, 5(1), 2009, 17-30. 24